Cargando…
Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the BC Cancer experience
BACKGROUND: Since 2012, the BC Cancer provincial treatment guideline for surgically staged stage IA/B and IC1 (defined by intraoperative rupture only) clear cell ovarian cancer (CCOC) has been to offer observation only. We reviewed the clinical outcomes of all stage I CCOC patients since policy impl...
Autores principales: | Liu, Shiru L., Tinker, Anna V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965725/ https://www.ncbi.nlm.nih.gov/pubmed/31970284 http://dx.doi.org/10.1016/j.gore.2019.100533 |
Ejemplares similares
-
Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008) -
Aspirin use correlates with survival in women with clear cell ovarian cancer
por: Wield, Alyssa M., et al.
Publicado: (2018) -
Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors
por: Nasioudis, Dimitrios, et al.
Publicado: (2019) -
Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021) -
Patterns of spread of clear cell ovarian cancer: Case report and case series()
por: Kumar, Aalok, et al.
Publicado: (2013)